Literature DB >> 33526846

Long non-coding RNA LINC02446 suppresses the proliferation and metastasis of bladder cancer cells by binding with EIF3G and regulating the mTOR signalling pathway.

Xiaotong Zhang1, Jiarun Zhang1, Wei Zhao1, Xiao Dong1, Peng Xin1, Xi Liu1, Xuejie Li1, Zhifei Jing1, Zhe Zhang1, Chuize Kong1, Xiuyue Yu2.   

Abstract

Accumulating evidence has been obtained to understand the mechanisms of long non-coding RNAs (lncRNAs) in bladder cancer (BC). However, due to the recurrence and metastasis of BC, searching for lncRNAs that are related to prognosis and metastasis and exploring the pathogenesis of BC might provide new insights for the treatment of BC. In the present study, we used the TCGA and GEO databases and identified LINC02446 as associated with prognosis and differentially expressed in bladder cancer tissues and para-cancer tissues. Then, we found that LINC02446 could affect the proliferation, migration and invasion of BC cells. Additionally, we found that LINC02446 could bind to the EIF3G protein and regulate the protein stability of EIF3G and then inhibit the mTOR signalling pathway. In summary, all these findings show that LINC02446 might serve as a promising therapeutic target for BC intervention.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc. part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33526846     DOI: 10.1038/s41417-020-00285-2

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  3 in total

1.  Eukaryotic translation initiation factor 3 subunit G promotes human colorectal cancer.

Authors:  Chenggang Yang; Yanbo Zhang; Wenfeng Du; Honggang Cheng; Chaobin Li
Journal:  Am J Transl Res       Date:  2019-02-15       Impact factor: 4.060

2.  [Report of Cancer Incidence and Mortality in China, 2014].

Authors:  W Q Chen; H Li; K X Sun; R S Zheng; S W Zhang; H M Zeng; X N Zou; X Y Gu; J He
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2018-01-23

3.  Prediction of recurrence in non-muscle invasive bladder cancer patients. Do patient characteristics matter?

Authors:  Burak Ucpinar; Akif Erbin; Ali Ayranci; Ufuk Caglar; Deniz Alis; Seref Basal; Omer Sarilar; Mehmet Fatih Akbulut
Journal:  J BUON       Date:  2019 Jul-Aug       Impact factor: 2.533

  3 in total
  4 in total

1.  Development and validation of pyroptosis-related lncRNAs prediction model for bladder cancer.

Authors:  Thongher Lia; Yanxiang Shao; Parbatraj Regmi; Xiang Li
Journal:  Biosci Rep       Date:  2022-01-28       Impact factor: 3.840

2.  Suppression of CCT3 Inhibits Tumor Progression by Impairing ATP Production and Cytoplasmic Translation in Lung Adenocarcinoma.

Authors:  Shuohua Chen; Yang Tian; Anji Ju; Boya Li; Yan Fu; Yongzhang Luo
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

3.  Characterization of the immune related lncRNAs in bladder cancer to aid immunotherapy.

Authors:  Ying Xiao; Yipeng Dong; Tiannan Yu; Rujie Wang; Yang Gao; Song Li; Shaojun Nong; Wenguang Li
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

4.  Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.

Authors:  Hao Wu; Zi-Yi Zhang; Ze Zhang; Xin-Ying Xiao; Sheng-Lin Gao; Chao Lu; Li Zuo; Li-Feng Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.